Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Return on Equity (2016 - 2025)

Dare Bioscience's Return on Equity history spans 8 years, with the latest figure at 4.75% for Q4 2025.

  • For Q4 2025, Return on Equity fell 1104.0% year-over-year to 4.75%; the TTM value through Dec 2025 reached 4.75%, down 1104.0%, while the annual FY2025 figure was 8.55%, 431.0% up from the prior year.
  • Return on Equity reached 4.75% in Q4 2025 per DARE's latest filing, down from 3.53% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 16.77% in Q3 2023 to a low of 39.35% in Q3 2024.
  • Average Return on Equity over 5 years is 3.87%, with a median of 1.03% recorded in 2022.
  • Peak YoY movement for Return on Equity: plummeted -5612bps in 2024, then surged 4289bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 1.11% in 2021, then crashed by -52bps to 1.68% in 2022, then surged by 603bps to 8.43% in 2023, then decreased by -25bps to 6.29% in 2024, then crashed by -175bps to 4.75% in 2025.
  • Per Business Quant, the three most recent readings for DARE's Return on Equity are 4.75% (Q4 2025), 3.53% (Q3 2025), and 1.66% (Q2 2025).